Revised SPCs: Cosentyx (secukinumab) 150 mg solution for injection in pre-filled pen and syringe

SPCs have been updated to reflect licence extension for treatment of moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.

Source:

electronic Medicines compendium